Begin typing your search...
Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla
Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
By
migrator
migrator
New Delhi
In August 2020, American vaccine company Novavax, Inc had announced a license agreement with SII for the development and commercialization of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.
''Covovax trials finally begin in India; the vaccine is made through a partnership with @Novavax and @SerumInstIndia. It has been tested against African and UK variants of #COVID19 and has overall efficacy of 89%. Hope to launch by September 2021!,'' Poonawalla said in a tweet.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
Next Story
